Company / Capital Expenditures
Savara Inc Capital Expenditures History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$25.0K
FY2024
5-year range
$9.0K / $296.0K
FY2020-FY2024
Trend
-91.6%
vs FY2023
Sector context
#185 of 194
Health Care
What the data says
Among 194 Health Care companies, Savara Inc is in the bottom 5% for capital expenditures. Capital Expenditures has fluctuated over the past 10 years, ranging from $8,000 in FY2016 to $495,000 in FY2017.
Based on SEC 10-K filings.
$25,000 in FY2024 with a 5-year CAGR of -29.2%.
Improved from $9,000 to $25,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -24.0%
- 5-Year CAGR
- -29.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 194This company $25.0K Sector average $117.5M
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -29.2%, indicating a declining trend.
- In FY2024, capital expenditures decreased 91.6% year-over-year.
- Ranks #185 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $25.0K | -91.6% |
| FY2023 | $296.0K | +3188.9% |
| FY2022 | $9.0K | -84.2% |
| FY2021 | $57.0K | +21.3% |
| FY2020 | $47.0K | -66.7% |
| FY2019 | $141.0K | +0.0% |
| FY2018 | $141.0K | -71.5% |
| FY2017 | $495.0K | +6087.5% |
| FY2016 | $8.0K | -95.2% |
| FY2015 | $165.0K | +12.2% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026